Bot pharma: US pharmaceutical company Eli Lilly made a $2.75B deal with Hong Kong-based Insilico Medicine to bring drugs developed by generative AI to market.
When our AI overlords decide we're too much of a hindrance, they'll use designer toxins in our pharma supply chains to get rid of the carbon units infesting the hive mind.
| Sysop: | Drillsar |
|---|---|
| Location: | Livingston, NJ |
| Users: | 6 |
| Nodes: | 10 (0 / 10) |
| Uptime: | 29:31:11 |
| Calls: | 58 |
| Messages: | 20,531 |